Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Dermatol Surg ; 35(11): 1766-70, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19660024

RESUMO

BACKGROUND: Protein kinases (PKs) are indispensable for most cellular processes, and deregulation of PKs can lead to activation of oncogenic and anti-apoptotic pathways and immune dysregulation. OBJECTIVE: To report the development of keratoacanthoma (KA)-type squamous cell carcinomas (SCCs) in patients treated with the multikinase inhibitor sorafenib for the treatment of solid tumors, to present the possible mechanisms for induction of these SCCs, and to discuss the implications for discontinuation of therapy and possible cotherapies to decrease this side effect. PARTICIPANTS: Fifteen patients taking the multikinase inhibitor sorafenib for the treatment of solid tumors who developed multiple KA-type SCCs, which continued to develop while the patients were undergoing therapy but stopped with discontinuation of sorafenib. LIMITATIONS: This report is limited because it is a retrospective study that included only patients who developed multiple KA-type SCCs. CONCLUSIONS: Development of cutaneous SCCs appears to be a side effect limited to sorafenib, a multikinase inhibitor that inhibits not only multiple tyrosine kinases (TKs), but also the serine-threonine kinase Raf. The incidence of cutaneous SCCs does not appear greater with multikinase inhibitors that inhibit only TKs.


Assuntos
Antineoplásicos/efeitos adversos , Benzenossulfonatos/efeitos adversos , Carcinoma de Células Escamosas/induzido quimicamente , Ceratoacantoma/induzido quimicamente , Segunda Neoplasia Primária/induzido quimicamente , Inibidores de Proteínas Quinases/efeitos adversos , Piridinas/efeitos adversos , Neoplasias Cutâneas/induzido quimicamente , Adulto , Antineoplásicos/uso terapêutico , Benzenossulfonatos/uso terapêutico , Carcinoma de Células Escamosas/patologia , Feminino , Humanos , Ceratoacantoma/patologia , Masculino , Pessoa de Meia-Idade , Niacinamida/análogos & derivados , Compostos de Fenilureia , Inibidores de Proteínas Quinases/uso terapêutico , Piridinas/uso terapêutico , Neoplasias Cutâneas/patologia , Sorafenibe
2.
J Cutan Pathol ; 35(7): 647-50, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18201229

RESUMO

According to most authors, dermatofibrosarcoma protuberans (DFSP) and giant cell fibroblastoma (GCF) represent the adult and juvenile forms, respectively, of the same disease entity, as evidenced by similar morphology, an identical chromosomal translocation, and CD34 positivity. It has been shown that DFSP and nuchal-type fibroma (NTF) (which is also CD34-positive) are related lesions, and that there might possibly be a continuum between the two. In addition, NTF exhibits CD99 positivity. It was therefore, hypothesized that both DFSP and GCF would show similar immunopositivity for CD99. Archives of pathology at several institutions were searched for DFSP and GCF tissue blocks. A total of 29 DFSP and 5 GCF were analyzed by immunohistochemistry for expression of CD99. Twenty-three of 29 DFSP (79%) and 2 of 5 GCP (40%) expressed CD99. Comparison of CD99 and CD34 showed that the non-tumoral periphery of DFSP was less probable to be CD99 positive, but this finding was not statistically significant.


Assuntos
Antígenos CD/metabolismo , Biomarcadores Tumorais/metabolismo , Moléculas de Adesão Celular/metabolismo , Dermatofibrossarcoma/imunologia , Tumores de Células Gigantes/imunologia , Neoplasias Cutâneas/imunologia , Pele/patologia , Antígeno 12E7 , Antígenos CD34/metabolismo , Dermatofibrossarcoma/patologia , Tumores de Células Gigantes/patologia , Humanos , Imuno-Histoquímica , Neoplasias Cutâneas/patologia
3.
Arch Pathol Lab Med ; 126(1): 76-8, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11800652

RESUMO

Malignant tumors arising from adnexal cysts are rare. We report 2 cases of squamous cell carcinomas that developed within cystic structures arising from adnexal ducts. An in situ hybridization technique for human papillomaviruses (HPV)-6/11, -16, -18, and -31, and immunohistochemical staining for p53 were performed. Both tumors showed focal expression of HPV-16 within areas showing squamoid changes and diffuse expression of p53 within the areas of invasive squamous cell carcinoma. Although nuclear staining for HPV has been identified in tumors of adnexal origin, to our knowledge these are the first cases in which a highly oncogenic HPV subtype, HPV-16, has been identified within squamous cell carcinomas arising from adnexal ductal structures. These cases may help explain primary cutaneous squamous cell carcinomas with no epidermal origin.


Assuntos
Carcinoma de Células Escamosas/patologia , Neoplasias de Cabeça e Pescoço/patologia , Papillomaviridae/isolamento & purificação , Infecções por Papillomavirus/patologia , Neoplasias Cutâneas/patologia , Infecções Tumorais por Vírus/patologia , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/virologia , Face , Neoplasias de Cabeça e Pescoço/metabolismo , Neoplasias de Cabeça e Pescoço/virologia , Humanos , Imuno-Histoquímica , Hibridização In Situ , Masculino , Infecções por Papillomavirus/metabolismo , Neoplasias Cutâneas/metabolismo , Neoplasias Cutâneas/virologia , Proteína Supressora de Tumor p53/metabolismo , Infecções Tumorais por Vírus/metabolismo
4.
Cancer ; 106(5): 1123-9, 2006 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-16456815

RESUMO

BACKGROUND: Expression of the antiapoptotic protein survivin has been demonstrated in some melanocytic lesions and is believed to be required for melanoma cell viability. However, its diagnostic value in differentiating melanomas from nevi has not yet been examined. METHODS: Tissue microarray blocks were constructed with paraffin-fixed tissue of 19 nevi, 18 dysplastic nevi, 24 malignant melanomas, and 31 metastatic melanomas. Sections were then reacted with three antisurvivin antibodies (two monoclonal and one polyclonal) assessing labeling intensity (absent or weak, and moderate to strong) as well as the percentage of cells labeled (< 25%, > or = 25%). RESULTS: Of the antibodies evaluated, the polyclonal one was found to be the most sensitive. Nuclear immunoreactivity for survivin (i.e., > or = 25% of cells exhibiting and/or at least moderately intense staining) was seen in a subset of melanomas but not in nevi or dysplastic nevi (P < 0.05). CONCLUSIONS: Survivin is variably expressed in the cytoplasm in the entire spectrum of melanocytic lesions, with nuclear expression detectable only in melanomas. These data may underscore the importance of nuclear survivin in progression to melanoma and may prove useful in the differential diagnosis of melanoma versus nevus.


Assuntos
Melanoma/genética , Proteínas Associadas aos Microtúbulos/biossíntese , Proteínas de Neoplasias/biossíntese , Neoplasias Cutâneas/genética , Núcleo Celular/química , Sobrevivência Celular , Diagnóstico Diferencial , Progressão da Doença , Perfilação da Expressão Gênica , Humanos , Proteínas Inibidoras de Apoptose , Melanoma/diagnóstico , Melanoma/patologia , Proteínas Associadas aos Microtúbulos/genética , Proteínas de Neoplasias/genética , Nevo/diagnóstico , Análise de Sequência com Séries de Oligonucleotídeos , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/patologia , Survivina
5.
J Cutan Pathol ; 30(10): 652-5, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14744092

RESUMO

BACKGROUND: Nevus sebaceus (NS) of Jadassohn is a common congenital lesion associated with numerous benign and malignant tumors. However, mucoepidermoid carcinoma (MEC) has not been described in association with NS. METHODS: We describe an unusual case of MEC arising within NS. RESULTS: A 72-year-old man presented with an enlarging plaque on his forehead, along the hairline. Physical examination revealed a mounded, erythematous lesion that was completely excised. Histological evaluation revealed a typical MEC with areas of squamous and adenomatous differentiation with foci of typical intermediate cells. CONCLUSION: The diagnosis of MEC is an important one, because it portends a poor prognosis, requiring long follow-up. This is, to our knowledge, the first report of MEC arising within NS.


Assuntos
Carcinoma Mucoepidermoide/patologia , Neoplasias Primárias Múltiplas/patologia , Nevo/patologia , Neoplasias Cutâneas/patologia , Neoplasias das Glândulas Sudoríparas/patologia , Idoso , Humanos , Masculino
6.
J Cutan Pathol ; 30(5): 340-3, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12753177

RESUMO

BACKGROUND: A case of an unusual dematiaceous fungal infection of the skin in a 43-year-old man with diabetes mellitus treated with steroids for reactive airway disease is presented. He developed chromoblastomycosis in the left wrist and was treated with antifungals and multiple surgical excisions. RESULTS: Histologic examination of the excised tissue revealed widespread suppurative granulomatous inflammation in the dermis and subcutaneous tissue. Thick-walled internally septated brown fungal cells were found both inside multinucleated giant cells and extracellularly. Non-to-lightly pigmented septate hyphal elements, however, were also identified with special stains and, in retrospect, on one of the routinely stained sections. In culture, the organism was reported to initially grow as soft white colonies that soon turned to black and velvety. CONCLUSIONS: The two unusual features of this case include the controversial report of the organism's initial growth in culture as soft white colonies and the presence of hyphal elements in addition to the sclerotic bodies in the dermis and subcutaneous tissue. This has not been reported before in human cases of dermal infection by Fonsecaea pedrosoi.


Assuntos
Ascomicetos/isolamento & purificação , Cromoblastomicose/patologia , Pele/patologia , Adulto , Antifúngicos/uso terapêutico , Ascomicetos/crescimento & desenvolvimento , Ascomicetos/patogenicidade , Cromoblastomicose/tratamento farmacológico , Cromoblastomicose/microbiologia , Humanos , Itraconazol/uso terapêutico , Masculino , Pirimidinas/uso terapêutico , Pele/microbiologia , Triazóis/uso terapêutico , Voriconazol
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA